California’s new Tobacco Cessation Policy Research Center will be located at UC Davis Comprehensive Cancer Center and funded with a $3.7 million state grant.
Read MoreResearcher Roy Ben-Shalom is developing a model that simulates changes in neuronal activity caused by ion channel mutations to select the most effective therapy for many neurodevelopmental conditions.
Read MoreResearchers have infused their first Wilson Disease patient with a gene therapy which has the potential to treat the underlying cause of the disease.
Read MoreThe development of engineered bone marrow is revolutionizing research and treatment for osteosarcoma, the most common malignant bone cancer in children.
Read MoreThe specialist you see first for your neck pain has a big impact on how your condition gets diagnosed and treated, a UC Davis study has found
Read MoreUC Davis exceeded $1 billion in external research funding in the fiscal year 2022–23. The School of Medicine contributed 40% of this amount, achieving a new research funding record.
Read MoreA new UC Davis Health study examined women’s understanding of lactational amenorrhea, the period of temporary infertility that accompanies exclusive breastfeeding.
Read MoreUC Davis hematologist Brian Jonas awarded the National Cancer Institute Research Specialist Award (R50) to further his leadership in NCI-funded cancer research.
Read MoreDown syndrome can mean more X-rays — and more radiation exposure — for children already at increased risk of cancer.
Read MoreUC Davis and the University of Oxford researchers developed a new software tool, SparkMaster 2, that allows scientists to analyze normal and abnormal calcium activity in cells.
Read MoreAn experimental medicine being tested at the UC Davis Eye Center uses gene therapy as a possible treatment for wet age-related macular degeneration or wet AMD.
Read MoreMIND Institute Director Leonard Abbeduto has co-authored a paper in the American Journal on Intellectual and Developmental Disabilities that calls for a paradigm shift in disability research.
Read MoreUC Davis clinicians are developing a multiteam strategy to boost rates of long-term use of buprenorphine among patients who seek care for opioid use disorder in emergency departments.
Read MoreResearch at UC Davis to uncover the potential causes of cancer in firefighters is getting a boost from a California climate action grant.
Read MoreGene therapy with microRNA-22 produced better survival outcomes than the current FDA-approved drug for liver cancer and without noticeable toxicity in new mouse study.
Read MoreThe Congress of Neurological Surgeons has named a paper by UC Davis Health neurosurgeon Kee Kim as the "2023 Top Spine Paper of the Year.”
Read MoreResearchers at UC Davis Health and Kennedy Krieger Institute have received a grant to develop a clinical tool to predict mental health concerns in adolescents following a concussion.
Read MoreResearchers in the Department of Psychiatry and Behavioral Sciences and the MIND Institute have received $4.7 million from the National Institute of Mental Health to test a child-focused autism intervention with community partners.
Read MoreA 5-year-old boy diagnosed with Duchenne muscular dystrophy is the first in California and fourth in the nation to receive groundbreaking gene therapy outside of clinical trials.
Read MoreUC Davis Comprehensive Cancer Center scientist receives $1.4 million federal grant to boost efforts finding a breakthrough treatment for late stage, drug-resistant prostate cancer.
Read More